Viewing Study NCT00131118


Ignite Creation Date: 2025-12-25 @ 4:59 AM
Ignite Modification Date: 2026-01-26 @ 9:13 PM
Study NCT ID: NCT00131118
Status: COMPLETED
Last Update Posted: 2017-06-01
First Post: 2005-08-15
Is NOT Gene Therapy: True
Has Adverse Events: False

Brief Title: Zoledronic Acid in Children (1 -17 Years) With Severe Osteogenesis Imperfecta
Sponsor: Novartis Pharmaceuticals
Organization:

Conditions & Keywords Data

Conditions:

Conditions

Condition Brief Condition Text View
None Osteogenesis Imperfecta View
Keywords:

Keywords

Keyword Brief Keyword Text View
None Osteogenesis Imperfecta, Brittle bone disease, bisphosphonate, children View